M, B., E, G., I, Y., S, M., U, H. G., N, T., . . . Ferrand, P. (2024). Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging, 51, 3496-3500. https://doi.org/10.1007/s00259-024-06803-w
Chicago-Zitierstil (17. Ausg.)M, Brendel, et al. "Neuroimaging Biomarkers in the Biological Definition of Parkinson’s Disease and Dementia with Lewy Bodies – EANM Position on Current State, Unmet Needs and Future Perspectives." European Journal of Nuclear Medicine and Molecular Imaging 51 (2024): 3496-3500. https://doi.org/10.1007/s00259-024-06803-w.
MLA-Zitierstil (9. Ausg.)M, Brendel, et al. "Neuroimaging Biomarkers in the Biological Definition of Parkinson’s Disease and Dementia with Lewy Bodies – EANM Position on Current State, Unmet Needs and Future Perspectives." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, 2024, pp. 3496-3500, https://doi.org/10.1007/s00259-024-06803-w.